Search

everythinglearnresearchcommunity

for

Search:↓

Adolescents with severe alopecia incur significantly higher healthcare costs.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Coenzyme Q10 may protect liver function but doesn't reduce hair loss from anthracycline antibiotics.

Nilotinib can cause generalized keratosis pilaris.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

Nilotinib may cause gray hair to return to its original color.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Imatinib can cause hair loss due to lichen planopilaris.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Nilotinib can cause keratosis pilaris, a skin condition.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

A woman's hair turned white after taking a cancer drug called dasatinib.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Follicle Stimulating Hormone is important for fertility.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.